Stock XOMA XOMA CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

All News XOMA Corporation

Equities

XOMA

US98419J2069

Market Closed - Nasdaq
Other stock markets
 21:00:00 27/06/2024 BST 		5-day change 1st Jan Change
22.9 USD +1.24% Intraday chart for XOMA Corporation -11.24% +23.78%
06-12 XOMA Receives $8.1 Million Milestone Related to Sale of Priority Review Voucher MT
05-09 Earnings Flash (XOMA) XOMA CORPORATION Reports Q1 Revenue $1.5M MT

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
XOMA Declares Quarterly Preferred Stock Dividends
AQ
XOMA Receives $8.1 Million Milestone Related to Day One Biopharmaceuticals Sale of its Priority Review Voucher
AQ
XOMA Receives $8.1 Million Milestone Related to Sale of Priority Review Voucher
MT
XOMA Receives $8.1 Million Milestone Related to Day One Biopharmaceuticals’ Sale of its Priority Review Voucher
AQ
XOMA to Present at H.C. Wainwright 2nd Annual Bioconnect Investor Conference at NASDAQ
AQ
Earnings Flash (XOMA) XOMA CORPORATION Reports Q1 Revenue $1.5M
MT
Xoma: Q1 Earnings Snapshot
AQ
XOMA Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
XOMA Reports First Quarter 2024 Financial Results and Highlights Recent Activities
AQ
XOMA : 2024 Letter to Shareholders
PU
XOMA Adds Economic Interests in Three First-in-Category Assets to its Royalty and Milestone Portfolio Including XACIATO™ (clindamycin phosphate) Vaginal Gel 2%
AQ
XOMA Corporation completed the acquisition of three First-in-Category Assets of Daré Bioscience, Inc. for $22 million.
CI
Leerink Partners Starts XOMA With Outperform Rating, $40 Price Target
MT
XOMA Earns $9 Million Milestone as FDA Grants Accelerated Approval to Day One’s OJEMDATM (tovorafenib) for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG)
AQ
XOMA : Acquisition/Asset Disposal - Form 8-K
PU
XOMA Corporation Announces Closing of Tender Offer
AQ
XOMA Corporation completed the acquisition of Kinnate Biopharma Inc..
CI
XOMA Declares Quarterly Preferred Stock Dividends
AQ
XOMA Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Kinnate Biopharma Inc.
AQ
Xoma: Q4 Earnings Snapshot
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. XOMA Stock
  4. News XOMA Corporation